Vale Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALE, and what generic alternatives to VALE drugs are available?
VALE has eighty-two approved drugs.
There are six US patents protecting VALE drugs.
There are forty-four patent family members on VALE drugs in twelve countries and forty-five supplementary protection certificates in thirteen countries.
Summary for Vale
International Patents: | 44 |
US Patents: | 6 |
Tradenames: | 63 |
Ingredients: | 50 |
NDAs: | 82 |
Patent Litigation for Vale: | See patent lawsuits for Vale |
Drugs and US Patents for Vale
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | LEVO-DROMORAN | levorphanol tartrate | TABLET;ORAL | 008720-001 | Dec 19, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Valeant Pharms Llc | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 086024-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Valeant Pharms North | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 076070-001 | Aug 16, 2002 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075116-004 | Dec 23, 1999 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vale
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharm Intl | PERMAX | pergolide mesylate | TABLET;ORAL | 019385-001 | Dec 30, 1988 | 4,180,582 | ⤷ Try a Trial |
Valeant Pharm Intl | PERMAX | pergolide mesylate | TABLET;ORAL | 019385-003 | Dec 30, 1988 | 4,180,582 | ⤷ Try a Trial |
Valeant Intl | RETIN-A | tretinoin | GEL;TOPICAL | 017579-002 | Approved Prior to Jan 1, 1982 | 4,247,547 | ⤷ Try a Trial |
Valeant Luxembourg | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,770,619 | ⤷ Try a Trial |
Valeant Pharm Intl | PERMAX | pergolide mesylate | TABLET;ORAL | 019385-001 | Dec 30, 1988 | 5,114,948 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 75 mg | ➤ Subscribe | 2011-06-06 |
➤ Subscribe | Extended-release Tablets | 200 mg | ➤ Subscribe | 2007-03-28 |
➤ Subscribe | Tablets | 1.1 g | ➤ Subscribe | 2013-11-05 |
➤ Subscribe | Extended-release Tablets | 100 mg | ➤ Subscribe | 2007-01-08 |
➤ Subscribe | Extended-release Tablets | 300 mg | ➤ Subscribe | 2007-09-25 |
➤ Subscribe | Cream | 0.5% | ➤ Subscribe | 2011-07-29 |
International Patents for Vale Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2797560 | ⤷ Try a Trial |
Mexico | 2009004826 | ⤷ Try a Trial |
Israel | 189104 | ⤷ Try a Trial |
Brazil | 112012027520 | ⤷ Try a Trial |
Canada | 2668441 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vale Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | 2013C/060 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506 |
0186118 | SPC/GB05/029 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218 |
1458369 | C01458369/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009 |
1458369 | SPC/GB10/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111 |
0591275 | SPC/GB05/030 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.